Epidemiology of prostatitis

Krieger, John N.; Lee, Shaun Wen Huey; Jeon, Jeonseong; Cheah, Phaik Yeong; Liong, Men Long; Riley, Donald E.

doi:10.1016/j.ijantimicag.2007.08.028

Cited by 315 publications

(205 citation statements)

References 28 publications

Supporting

Mentioning

169

Contrasting

Unclassified

Order By: Relevance

“…The analyses of more than 12 000 men confirm other studies [2] which demonstrate that CP represents a large problem in adult male populations. Even the numbers that are seen in urology clinics may under represent the true magnitude of these symptom profiles that are observed.…”

supporting

confidence: 86%

Comment on “Treatment of chronic prostatitis in Chinese men” by Liang CZ et al. in Asian Journal of Andrology

Getzenberg¹

2009

Asian J Androl

View full text Add to dashboard Cite

The manuscript by Liang et al. [1] entitled Treatment of chronic prostatitis in Chinese men appears to be an important and comprehensive analysis of the issue of chronic prostatitis (CP) as well as treatment avenues that are pursued within a Chinese population. The analyses of more than 12 000 men confirm other studies [2] which demonstrate that CP represents a large problem in adult male populations. Even the numbers that are seen in urology clinics may under represent the true magnitude of these symptom profiles that are observed. This study also confirms the fact that antibiotics, as commonly used, do not seem to have much efficacy within this group. As a number of investigators [3] have demonstrated, CP is more than just a bacterial infection and may not even be an infection at all. The unique aspects of this manuscript from my perspective are the large numbers of patients that were analyzed as well as the unique nature of this population. It reaffirms our desperate need to understand more about the disease of CP and its underlying mechanisms. This information is necessary in order to understand how to provide some relief to these large numbers of men presenting with this disease.

show abstract

supporting

confidence: 86%

Comment on “Treatment of chronic prostatitis in Chinese men” by Liang CZ et al. in Asian Journal of Andrology

Getzenberg¹

2009

Asian J Androl

View full text Add to dashboard Cite

show abstract

“…Based on a population of >10 600 participants, a systematic review found an 8.2% prevalence of prostatitis symptoms [1].…”

Section: Introductionmentioning

confidence: 99%

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Rees

Abrahams

Doble³

et al. 2015

BJU International

246

193

View full text Add to dashboard Cite

ObjectivesTo improve awareness and recognition of chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non-specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP/CPPS, in both non-specialist and specialist settings. To promote efficient referral of care between nonspecialists and specialists and the involvement of the multidisciplinary team (MDT). Patients and MethodsThe guideline population were men with CBP or CP/CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP/CPPS (published between 1999 and February 2014). A Delphi panel process was used where high-quality, published evidence was lacking. ResultsCBP and CP/CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms (LUTSvoiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first-line treatment include antibiotics, a-adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. ConclusionChronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom-based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP/CPPS.

show abstract

“…Epidemiologic studies report that the prevalence of prostatitis-like symptoms is approximately similar to diabetes mellitus and ischemic heart disease. The rate of prostatitis-like symptoms was reported to range from 2.2% to 9.7%, and mean prevalence was 8.2% [1].…”

Section: Introductionmentioning

confidence: 99%

Recent trend of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) management

Lee

2017

Hanyang Med Rev

View full text Add to dashboard Cite

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition. However, many of the traditional therapies like monotherapy used in clinical practice fail to show efficacy. There is no one particular treatment to be recommended as monotherapy for CP/CPPS. The new concept of treatment which is 'UPOINT' is introduced. The major barrier in treating men with CP/CPPS is the heterogenous nature of this syndrome. In order to treat appropriately, the patient should be evaluated individually to assess the nature of symptoms. To evaluate patients with chronic urologic pelvic pain, a six-point clinical phenotyping system has been developed. The clinical domains are urinary symptoms, psychosocial dysfunction, organ specific findings, infection, neurologic/systemic, and tenderness of muscles, which produces the acronym 'UPOINT' . This clinical phenotyping system may provide a useful and clinically relevant framework for multimodal therapy for the treatment of CP/CPPS. However, the concept of UPOINT needs randomization, placebo or sham control studies to show verified treatment.

show abstract

Epidemiology of prostatitis

Cited by 315 publications

References 28 publications

Comment on “Treatment of chronic prostatitis in Chinese men” by Liang CZ et al. in Asian Journal of Andrology

Comment on “Treatment of chronic prostatitis in Chinese men” by Liang CZ et al. in Asian Journal of Andrology

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Recent trend of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) management

Contact Info

Product

Resources

About